Day: October 18, 2026

Discover how orphan drug designation works in 2026. Compare FDA and EMA eligibility criteria, rare disease prevalence thresholds, scientific evidence requirements, and regulatory incentives. Learn what pharmaceutical sponsors need to prepare for successful regulatory submissions